Hatim Husain

6PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Oct 29, 2025
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz

|Mar 25, 2024
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.

Christian D Rolfo, Russell W Madison, Lincoln W Pasquina

|Oct 20, 2022
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples.

Hatim Husain, Dean C Pavlick, Bernard J Fendler

Pageof 1